Ledger.Open graph →
SEC Form D · Amendment · filed July 1, 2016

AGH Therapeutics, Inc

Offering
$4.5M
Sold
$600K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NASHVILLE, TN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Thomas G. Andrews · Nashville, TNDirectorLawrence G. Greer · Nashville, TNDirectorMatthew A. Gonda · Nashville, TNExec · DirectorJerry M. Kluft · Nashville, TNDirectorRaymond M. Pirtle · Nashville, TNDirectorKyle Forster · Santa Clara, CADirectorMichael Mazzei · New York, NYDirectorErez Chimovits · Menlo Park, CAExec · DirectorTimothy A. Staley · Wilmington, DEDirectorRichard T. Schumacher · South Easton, MADirectorJonathan Silverstein · Menlo Park, CADirectorBurr Vail · Vieques, Puerto RicoExec · DirectorStephen Pollack · Calabasas, CADirectorRaymond M. Pirtle · Nashville, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗